These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10989121)
1. What causes the build-up of ubiquitin-containing inclusions in Parkinson's disease? Andersen JK Mech Ageing Dev; 2000 Sep; 118(1-2):15-22. PubMed ID: 10989121 [TBL] [Abstract][Full Text] [Related]
2. Glutathione decreases in dopaminergic PC12 cells interfere with the ubiquitin protein degradation pathway: relevance for Parkinson's disease? Jha N; Kumar MJ; Boonplueang R; Andersen JK J Neurochem; 2002 Feb; 80(4):555-61. PubMed ID: 11841562 [TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-proteasome system and Parkinson's diseases. Betarbet R; Sherer TB; Greenamyre JT Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758 [TBL] [Abstract][Full Text] [Related]
4. Glutathione, iron and Parkinson's disease. Bharath S; Hsu M; Kaur D; Rajagopalan S; Andersen JK Biochem Pharmacol; 2002 Sep; 64(5-6):1037-48. PubMed ID: 12213603 [TBL] [Abstract][Full Text] [Related]
5. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533 [TBL] [Abstract][Full Text] [Related]
6. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease. Liani E; Eyal A; Avraham E; Shemer R; Szargel R; Berg D; Bornemann A; Riess O; Ross CA; Rott R; Engelender S Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5500-5. PubMed ID: 15064394 [TBL] [Abstract][Full Text] [Related]